Literature DB >> 9321727

Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA.

R Coello1, J R Glynn, C Gaspar, J J Picazo, J Fereres.   

Abstract

In hospital outbreaks of methicillin-resistant Staphylococcus aureus (MRSA) many patients are initially colonized without infection. The reasons why some progress to infection while others do not are not known. A cohort of 479 hospital patients, initially only colonized with MRSA, was followed prospectively for the development of MRSA infection. Risk factors for progression to infection were assessed using Cox proportional hazards survival analysis. Fifty-three patients (11.1%) developed 68 MRSA infections. Intensive care setting, administration of three or more antibiotics, ulcers, surgical wounds, nasogastric or endotracheal tubes, drains, and urinary or intravenous catheterization were all associated with increased rates of MRSA infection. Multivariate analysis showed that intensive care patients, compared with medical patients, had a higher rate of developing MRSA infection within the first four days of admission, with a hazard ratio of 26.9 (95% CI 5.7-126). Surgical wounds, pressure ulcers and intravenous catheterization were also independent risk factors, with hazard ratios (and 95% CI) of 2.9 (1.3-6.3); 3.0 (1.6-5.7) and 4.7 (1.4-15.6), respectively. These findings suggest that, during an MRSA outbreak, clinical infection would be reduced if surgical and intensive care patients received priority for the prevention of initial colonization with MRSA. Prevention of pressure ulcers, and strict aseptic care of intravenous catheters and surgical wounds would also reduce the development of MRSA infection. Since early treatment with vancomycin is known to reduce the mortality, patients colonized with MRSA who also have one or more of these risk factors may warrant empirical vancomycin therapy at the earliest suggestion of infection.

Entities:  

Mesh:

Year:  1997        PMID: 9321727     DOI: 10.1016/s0195-6701(97)90071-2

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  47 in total

1.  Recognition of two groups of methicillin-resistant Staphylococcus aureus strains based on epidemiology, antimicrobial susceptibility, hypervariable-region type, and ribotype in Finland.

Authors:  S Salmenlinna; J Vuopio-Varkila
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

2.  [Epidemiology of and preventive measures for multiresistant pathogens].

Authors:  E-B Kruse; M Dettenkofer
Journal:  Ophthalmologe       Date:  2010-04       Impact factor: 1.059

3.  Screening cardiac surgery patients for MRSA: an economic computer model.

Authors:  Bruce Y Lee; Ann E Wiringa; Rachel R Bailey; Vishal Goyal; G Jonathan Lewis; Becky Y K Tsui; Kenneth J Smith; Robert R Muder
Journal:  Am J Manag Care       Date:  2010-07-01       Impact factor: 2.229

4.  Screening strategies in surveillance and control of methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  J V Robotham; D R Jenkins; G F Medley
Journal:  Epidemiol Infect       Date:  2006-07-13       Impact factor: 2.451

5.  Impact of a short period of pre-enrichment on detection and bacterial loads of methicillin-resistant Staphylococcus aureus from screening specimens.

Authors:  L Van Heirstraeten; J Cortiñas Abrahantes; C Lammens; A Lee; S Harbarth; G Molenberghs; M Aerts; H Goossens; S Malhotra-Kumar
Journal:  J Clin Microbiol       Date:  2009-08-12       Impact factor: 5.948

6.  Prevalence of MRSA colonization in an adult urban Indian population undergoing orthopaedic surgery.

Authors:  Sanjay Agarwala; Dnyanesh Lad; Vikas Agashe; Anshul Sobti
Journal:  J Clin Orthop Trauma       Date:  2015-09-11

7.  Staphylococcal enterotoxin P predicts bacteremia in hospitalized patients colonized with methicillin-resistant Staphylococcus aureus.

Authors:  Michael S Calderwood; Christopher A Desjardins; George Sakoulas; Robert Nicol; Andrea Dubois; Mary L Delaney; Ken Kleinman; Lisa A Cosimi; Michael Feldgarden; Andrew B Onderdonk; Bruce W Birren; Richard Platt; Susan S Huang
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

8.  Long-term risk for readmission, methicillin-resistant Staphylococcus aureus (MRSA) infection, and death among MRSA-colonized veterans.

Authors:  Nestor M Quezada Joaquin; Daniel J Diekema; Eli N Perencevich; George Bailey; Patricia L Winokur; Marin L Schweizer
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

Review 9.  Treatment strategies for methicillin-resistant Staphylococcus aureus infections in pediatrics.

Authors:  Jason G Newland; Gregory L Kearns
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

10.  Financial implications of plans to combat methicillin-resistant Staphylococcus aureus (MRSA) in an orthopaedic department.

Authors:  K Hassan; C Koh; D Karunaratne; C Hughes; S N Giles
Journal:  Ann R Coll Surg Engl       Date:  2007-10       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.